Exploring the potential of retinoic acid in treating non-APL Acute Myeloid Leukemia through differentiation therapy and combination treatments.
Discover how AS1411, a revolutionary DNA aptamer, reprograms leukemia cells through differentiation therapy, offering new hope for AML treatment.